AbbVie's Q2 Results Expected to be Inline With Expectations, RBC Says
() -- AbbVie's (ABBV) Q2 financial results are expected to be in line with expectations, RBC Capital Markets analysts said in a Friday note. The company is scheduled to report its Q2 financial results on July 31. Analysts said sentiment on AbbVie has changed significantly, especially after the recent Apogee deal, which